エピソード

  • MDT Today - Aug 13: Slight Gain Amidst Competition
    2026/08/13
    Hey there! I’m Joey, a longtime investor here to break down the day for you. Today we’re talking about Medtronic, and it was a pretty chill day, moving up just a smidge, like 0.5%.

    So, what went down? Medtronic had a decent day, barely moving but still in the green. It seems like folks were feeling okay about it, but nothing too wild. It was a slow bleed earlier in the day, but by the time the closing bell rang, it managed to inch upwards.

    Now, why the slight bump? Well, it looks like some analysts are keeping an eye on Medtronic and think it’s still got some potential. They’re revisiting it alongside other stocks, which is always a good sign. Plus, it outperformed some competitors today, which definitely helped. People are still trying to figure out if it’s a bargain, especially after some recent wins with CE marking. But let’s be real—there's a lot of chatter about competitors, particularly Intuitive, making waves and crowding out some of Medtronic's market space. That’s gotta sting a little, right?

    On the horizon, there’s buzz about how Western Wealth Management has a notable position in Medtronic. It’s always interesting to see big players making moves in a stock. That could mean they see something we don’t, or they’re just riding the wave.

    So, to wrap it up, Medtronic had a quiet day, but a little gain is still a gain! Keep an eye on those competitors, though. Remember, this is just for info and fun—no financial advice here. Catch you later!
    続きを読む 一部表示
    1 分
  • MDT Today - Aug 12: CE Mark Win Sparks Interest
    2026/08/12
    Hey, what’s up? It’s Joey here, your friendly longtime investor, breaking down the day. So, let’s talk about Medtronic, or MDT for short. Today was a bit of a red day—down about 1.2%. Ouch.

    So, what went down? The stock hit a little bump after a recent CE mark win, which usually would be good news. But today, it kinda got smoked. It opened strong but then just faded away. Volume was pretty steady, so it wasn’t like people were panicking or anything; it just seemed like a slow bleed.

    Now, why the drop? Well, folks are still trying to figure out if Medtronic really trades at a discount after that CE mark win. Some analysts are saying it’s a good time to buy, while others aren’t so sure. Plus, UBS upgraded the stock recently, saying there’s strong growth in their cardiac division. You’d think that would get people excited, but it seems like investors are a bit cautious. Maybe they’re waiting to see if that growth actually translates into solid numbers.

    Oh, and here’s a quick thing worth knowing: Cardinal Capital just upped their stake in Medtronic. That’s usually a sign someone’s feeling optimistic, even if the stock isn’t showing it right now.

    So, yeah, a bit of a mixed bag today for MDT. It’s like when you’re waiting for your favorite show to drop a new season, and it turns out to be a little disappointing. But, hey, that’s just how the market rolls sometimes. Just remember, this is all for your info and entertainment. I’m not giving any buy or sell advice here. Catch you later!
    続きを読む 一部表示
    1 分
  • MDT Today - Aug 11: Trust Cuts Position
    2026/08/11
    Hey there! It’s Joey here, your friendly longtime investor breaking down the day. Today, we’re talking about Medtronic, and guess what? It was a green day! The stock was up about 1.1%.

    So, what went down? Medtronic had a pretty solid trading day overall. It outperformed some competitors, which is always nice to see. But it wasn’t all sunshine. There was some chatter about Perkins Coie Trust cutting its stock position in Medtronic. Yeah, that one stung a bit for investors.

    Now, why did all this happen? Well, some analysts are still keeping a neutral rating on Medtronic, especially when it comes to their renal coverage. It's a bit of a mixed bag. On one hand, it's good to see Medtronic holding its ground against others in the healthcare space. On the other hand, with that trust cutting their position, it might have made some investors a little jittery.

    Also, there’s been some buzz comparing Medtronic to Johnson & Johnson after their earnings reports. Analysts are trying to figure out which stock is better positioned, and that’s always a hot topic.

    One quick thing to keep in mind: Medtronic continues to be spotlighted by some of Wall Street's most accurate analysts, who think it’s among the healthcare stocks delivering solid dividend yields. So, while today had its ups and downs, there’s still some positive chatter out there.

    That’s a wrap for today! Just remember, I’m here to keep you in the loop, not to give any financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • MDT Today - Aug 10: Neutral Rating Holds Stock Steady
    2026/08/10
    Hey there! It’s Joey here, your friendly investor buddy. I’ve been in the game for a while, and today we’re talking about Medtronic, which had a little green day, up about 1.4%. Not a huge surge, but hey, green is good, right?

    So, what went down? Medtronic’s stock ticked up a bit, but it wasn’t like everyone was rushing to buy. It seems people were kind of chill about it. The volume was normal, so nothing crazy there. Just a steady day for the stock.

    Now, why did it move this way? Well, Piper Sandler kept its rating on Medtronic neutral. That means they’re not super excited, but they’re not throwing shade either. It’s like a “meh” but in a nice way. They mentioned something about renal coverage, which might be a factor in how investors are feeling. But honestly, it sounds like nobody's really sure what the market thinks about Medtronic right now. The articles didn’t spill much tea on any big news that would really shake things up.

    Also, in case you're curious, there’s a bit of chatter about Medtronic being compared to Intuitive Surgical. That’s another MedTech company that’s been in the spotlight, and some folks are trying to figure out which one’s the better pick. It’s a classic showdown in the med-tech world, but nothing definitive yet.

    To wrap it up, Medtronic’s stock had a modest gain today, but there’s a bit of uncertainty hanging in the air. It seems like investors are taking a wait-and-see approach, and who can blame them? Just remember, I’m here to share info and keep it light. No financial advice from me, just good vibes and stock talk. Catch you later!
    続きを読む 一部表示
    1 分
  • MDT Today - Aug 09: Strong Trading Day
    2026/08/09
    Hey there! It’s Joey, your friendly investor buddy, here breaking down what went down with Medtronic today. So, MDT had a pretty solid day, finishing up about 1.4%. Not too shabby, right?

    What happened today? Well, the stock got some love and was moving up nicely, outperforming a bunch of its competitors. You know how it goes—when one stock does well, it kinda drags others along with it. The trading volume was pretty strong too, matching its average, so there was definitely some action happening.

    Now, why did it perform like this? First off, there was some buzz about Medtronic's recent win with a new CE mark, which is a big deal in the MedTech world. It’s like getting a gold star for meeting certain safety and performance standards in Europe. That kind of news usually boosts confidence in the stock. Plus, there were some comparisons floating around between Medtronic and Intuitive Surgical, and it looks like Medtronic was holding its ground pretty well in that matchup. Always nice to see your stock holding its own, right?

    And here's a little nugget for you: NewEdge Advisors just trimmed their position in Medtronic. Sometimes that can freak investors out, but it also shows that people are keeping a close eye on the stock. It’s a mixed bag, but nothing too wild happened there.

    To wrap it all up, Medtronic had a strong trading day, riding that wave of good news and showing some resilience against competitors. Always something going on in this wild world of stocks! Just remember, I’m here to share info, not to tell you what to do with your money. Catch you later!
    続きを読む 一部表示
    1 分
  • MDT Today - Aug 08: CE Mark Win Boosts Stock
    2026/08/08
    Hey there! It's Joey, your friendly investing buddy, here to break down the day for you. Today, we're chatting about Medtronic, and guess what? It had a pretty solid green day, up about 1.4%. Nice to see that!

    So, what went down? Medtronic's stock picked up some steam mainly because they snagged an expanded CE mark for their Affera system. This is a big deal for treating ventricular arrhythmias. Basically, it's like getting a thumbs up from European regulators, which opens doors for more sales and use of their tech. That news got people feeling good about the stock, and they jumped in.

    Now, why did this matter? Investors love when companies get regulatory wins like this. It signals that the company’s products are not just good, but also recognized as safe and effective in the market. Plus, it adds a layer of credibility. You know how it is—good news travels fast in the stock world, and everyone wants a piece of the action when something positive happens. That CE mark was a cherry on top, especially since Medtronic has been seen as a bit undervalued lately.

    On top of that, we saw a couple of investment firms buying up shares. Gradient Investments and Beacon Investment Advisory both scooped up some Medtronic stock. This kind of activity usually shows confidence in the company’s future. When big players are buying in, it can give smaller investors a bit of a nudge to pay attention too.

    One more thing to keep an eye on: Medtronic has been outperforming its competitors lately. While some other companies in the same space are struggling, Medtronic seems to be holding its ground pretty well. It’s always good to know who’s ahead in the race, right?

    So, to wrap it all up, Medtronic had a solid day thanks to that CE mark win, and it’s looking like it’s in a good spot compared to its rivals. Just remember, this info is just for fun and to keep you in the loop—no financial advice here.

    Catch you later!
    続きを読む 一部表示
    2 分
  • MDT Today - Aug 07: Palouse Capital Buys In
    2026/08/07
    Hey there! It’s Joey here, your friendly neighborhood investor. Today, we’re talking about Medtronic, and it was a bit of a mixed bag. The stock was up just a smidge, closing at about 86.34, which is a 0.49% bump. Not exactly a wild ride, but hey, a win’s a win, right?

    So, what happened? Well, it was a pretty chill day for MDT. The volume was right on par with its average, so nothing too crazy there. But here’s the scoop: Palouse Capital Management decided to grab nearly 30,000 shares of Medtronic. That’s a solid move and likely gave some investors a little boost of confidence. On the flip side, Balefire LLC sold off a chunk of shares too—over 25,000. So, it’s like a mixed bag of vibes. Some folks are all in, while others are cashing out.

    Now, why did MDT get a bit of attention today? The buzz seems to be around those share transactions. When big players like Palouse step in, it can create some chatter. Plus, there’s been some chatter on the internet about Medtronic potentially soaring 40% by the end of the year. That’s a bold claim, and honestly, nobody knows if it’ll actually happen. But it’s definitely getting people talking.

    Oh, and here’s something to keep in mind: Medtronic’s been working on some new tech for mapping and ablating ventricular arrhythmias. That could be a game changer and might be where some of the excitement is coming from.

    So, to wrap it up: MDT had a slight gain today, with some interesting moves in the share market. There’s a mix of optimism and caution in play, and it’s all about how those big buys and sells shake out. Just remember, this is all for your info and entertainment, not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • MDT Today - Aug 06: Stock Stays Flat
    2026/08/06
    Hey there! It’s Joey, your friendly neighborhood investor, here to break down the day for you. Today, we’re chatting about Medtronic, and guess what? It was a pretty chill day – stock barely moved, staying flat. No up, no down, just sitting at 85.99.

    So, what’s the scoop? Well, it seems like everyone was just hanging tight. Volume was right on the average, so nothing crazy happened. Medtronic didn’t give us any wild news or big announcements that would shake things up. It’s like the calm before a storm, or maybe just a lazy Sunday afternoon vibe in the market.

    Now, the buzz is mostly around some analysts getting pretty optimistic about Medtronic. Some folks are throwing around predictions that it could soar 40% by year-end. I mean, who wouldn’t want to hear that, right? But let’s be real, that’s a bold claim, and it’s not set in stone. The chatter from places like The Motley Fool and Globe and Mail is definitely getting people’s attention. They’re hyping up Medtronic’s potential, especially with some exciting tech developments in the pipeline.

    Speaking of tech, did you catch that Sphere-9 news? They’re doing some cool stuff with mapping and ablating ventricular arrhythmias using two energies. Sounds fancy, right? It’s all about improving heart health, and Medtronic’s got a foot in that door. That’s always a good look in the healthcare world.

    One more thing worth knowing: there’s a lot of talk about Medtronic possibly hitting “Dividend King” status soon. That’s a title that comes with some serious street cred in the investing community. It means they’d be consistently raising their dividends for many years, which is a big deal for income-focused investors.

    So, to wrap it up, Medtronic had a quiet day. Analysts are feeling optimistic, and there’s some interesting tech stuff happening that could impact the future. Just remember, I’m here to keep you in the loop, not to give you financial advice. Keep it real, and catch you later!
    続きを読む 一部表示
    2 分